Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Natera, Inc. (NTRA : NSDQ)

• Company Description    Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. Number of Employees: 4,434

• Price / Volume Information    Yesterday's Closing Price: $173.81 Daily Weekly Monthly 20 Day Moving Average: 978,479 shares Shares Outstanding: 137.25 (millions) Market Capitalization: $23,855.09 (millions) Beta: 1.68 52 Week High: $183.00 52 Week Low: $117.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.70% 7.72% 12 Week 1.66% -7.71% Year To Date 9.80% -1.97%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 13011 McCallen Pass Building A Suite 100 - Austin,TX 78753 USA ph: 650-980-9190 fax: - investor@natera.com http://www.natera.com

• General Corporate Information    Officers Steve Chapman - Chief Executive Officer and President Matthew Rabinowitz - Executive Chairman Michael Brophy - Chief Financial Officer Roy Baynes - Director Roelof F. Botha - Director Peer Information Natera, Inc. (CHCR) Natera, Inc. (ESRX) Natera, Inc. (MYDP) Natera, Inc. (COR) Natera, Inc. (GBCS) Natera, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 632307104 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 137.25 Most Recent Split Date: (:1) Beta: 1.68 Market Capitalization: $23,855.09 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.40 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.00 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 19.05 Price/Cash Flow: - Price / Sales: 12.14 EPS Growth vs. Year Ago Period: -146.67% vs. Previous Quarter: -48.00% Sales Growth vs. Year Ago Period: 32.24% vs. Previous Quarter: 8.92% ROE 06/30/25 - -22.22 03/31/25 - -18.29 12/31/24 - -20.56 ROA 06/30/25 - -15.03 03/31/25 - -11.68 12/31/24 - -12.21 Current Ratio 06/30/25 - 3.72 03/31/25 - 3.87 12/31/24 - 4.00 Quick Ratio 06/30/25 - 3.58 03/31/25 - 3.74 12/31/24 - 3.87 Operating Margin 06/30/25 - -12.89 03/31/25 - -10.36 12/31/24 - -11.22 Net Margin 06/30/25 - -12.89 03/31/25 - -10.36 12/31/24 - -11.22 Pre-Tax Margin 06/30/25 - -12.90 03/31/25 - -10.34 12/31/24 - -11.18 Book Value 06/30/25 - 9.13 03/31/25 - 9.17 12/31/24 - 9.05 Inventory Turnover 06/30/25 - 14.73 03/31/25 - 15.14 12/31/24 - 15.19 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©